MKI67 and melanoma: Previous studies have linked decreased frequencies of Ki67+ Eomes+ CD4+ T cells with irAE [26], while increased levels of Ki67+ PD1+ CD8+ T cells are linked to prolonged progression-free survival in melanoma patients treated with anti-PD-1 therapy [27].